Skip to main content

Branch Retinal Vein Occlusion

  • Chapter
  • First Online:
Retinal Vascular Disease

Part of the book series: Retina Atlas ((RA))

  • 554 Accesses

Abstract

Branch retinal vein occlusion (BRVO) was first described in 1855 as a “retinal apoplexy” by Liebreich (Liebreich 1855) and as thrombotic in nature by von Michel in 1878 (von Michel 1878).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • BVOS Group. Argon laser photocoagulation for macular edema in branch vein occlusion. Branch vein occlusion study group. Am J Ophthalmol. 1984;98:271–82.

    Article  Google Scholar 

  • BVOS Group. Argon scatter laser photocoagulation for prevention of neovascularization and vitreous hemorrhage in branch vein occlusion. A randomized clinical trial. The branch vein occlusion study group. Arch Ophthalmol. 1986;104:34–41.

    Article  Google Scholar 

  • Campochiaro PA, Hafiz G, Mir TA, et al. Scatter photocoagulation does not reduce macular edema or treatment burden in patients with retinal vein occlusion: the RELATE trial. Ophthalmology. 2015;122:1426–37.

    Article  Google Scholar 

  • Campochiaro PA, Heier JS, Feiner L et al. for BRAVO investigators. Ranibizumab for macular edema following BRVO: six-month primary end points of a phase III study. Ophthalmology. 2010;117:1102–1112. e.1101.

    Google Scholar 

  • Campochiaro PA, Sophie R, Pearlman J, et al. Long term outcomes in patients with retinal vein occlusion treated with ranibizumab: the RETAIN study. Ophthalmology. 2014;121:209–19.

    Article  Google Scholar 

  • Cheung N, Klein R, Wang JJ, et al. Traditional and novel cardiovascular risk factors for retinal vein occlusion: the multiethnic study of atherosclerosis. Invest Ophthalmol Vis Sci. 2008;49:4297–302.

    Article  Google Scholar 

  • Christoffersen NL, Larsen M. Pathophysiology and hemodynamics of branch retinal vein occlusion. Ophthalmology. 1999;106(11):2054–62.

    Article  CAS  Google Scholar 

  • Clark WL, Boyer DS, Heier JS, et al. Intravitreal aflibercept for macular edema following branch retinal vein occlusion: the 52-week results of the VIBRANT study. Ophthalmology. 2016;123:330–6.

    Article  Google Scholar 

  • Feist RM, Ticho BH, Shapiro MJ, Farber M. Branch retinal vein occlusion and quadrantic variation in arteriovenous crossings. Am J Ophthalmol. 1992;113:664–8.

    Article  CAS  Google Scholar 

  • Haller JA, Bandello F, Belfort R, et al. Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion 12 month study results. Ophthalmology. 2011;118:2453–60.

    Article  Google Scholar 

  • Hayreh S. Prevalent misconceptions about acute retinal vascular occlusive disorders. Prog Retin Eye Res. 2005;24:493–519.

    Article  Google Scholar 

  • Hayreh SS, Rojas P, Podhajsky P, et al. Ocular neovascularization with retinal vascular occlusion- III. Incidence of ocular neovascularization with retinal vein occlusion. Ophthalmology. 1983;90(5):488–506.

    Article  CAS  Google Scholar 

  • Hayreh SS, Zimmerman B, Podhajsky P. Incidence of various types of retinal vein occlusion and their recurrence and demographic characteristics. Am J Ophthalmol. 1994;117:429–41.

    Article  CAS  Google Scholar 

  • Heier JS, Campochiaro PA, Yau L, et al. Ranibizumab for macular edema due to retinal vein occlusions: long term follow-up in the HORIZON trial. Ophthalmology. 2012;119:802–9.

    Article  Google Scholar 

  • Klein R, Moss SE, Meuer SM, Klein BE. The 15 year cumulative incidence of retinal vein occlusion: the beaver dam eye study. Arch Ophthalmol. 2008;126(4):513–8.

    Article  Google Scholar 

  • Lam HD, Lahey JM, Kearney JJ, et al. Young patients with branch retinal vein occlusion: a review of 60 cases. Retina. 2010;30(9):1520–3.

    Article  Google Scholar 

  • Liebreich R. Ophthalmoskopische Notizen: Ueber die Farbe des Augengrundes. Albrech Von Graefes Arch Ophthalmol. 1855;1:333–43.

    Article  Google Scholar 

  • Mitchell P, Smith W, Chang A. Prevalence and associations of retinal vein occlusion in Australia. The Blue Mountains eye study. Arch Ophthalmol. 1996;114(10):1242–7.

    Article  Google Scholar 

  • Rogers S, McIntosh RL, Cheung N, et al. Pooled data from population studies from the United States, Europe, Asia and Australia. Ophthalmology. 2010a;117:313–9.

    Article  Google Scholar 

  • Rogers SL, McIntosh RL, Lim L, et al. Natural history of branch retinal vein occlusion: an evidence based systemic review. Ophthalmology. 2010b;117(6):1094–1101.e5.

    Article  Google Scholar 

  • Rush RB, Simunovic MP, Aragon AV 2nd, Ysasaga JE. Treat-and-extend intravitreal bevacizumab for branch retinal vein occlusion. Ophthalmic Surg Lasers Imaging Retina. 2014;45:212–6.

    Article  Google Scholar 

  • Scott IU, Ip MS, Van Veldhuisen PC, et al. A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with standard care to treat vision loss associated with macular edema secondary to branch retinal vein occlusions: the standard care vs corticosteroid for retinal vein occlusion (SCORE) study report 6. Arch Ophthalmol. 2009;127:1115–28.

    Article  Google Scholar 

  • Tadayoni R, Waldstein SM, Boscia F, et al. Sustained benefits of ranibizumab with or without laser in branch retinal vein occlusion – 24month results of the BRIGHTER study. Ophthalmology. 2017;124(12):1778–87.

    Article  Google Scholar 

  • Tan MH, McAllister IL, Gillies ME, et al. Randomized controlled trial of intravitreal ranibizumab versus standard grid laser for macular edema following branch retinal vein occlusion. Am J Ophthalmol. 2014;157:237–247.e1.

    Article  CAS  Google Scholar 

  • Trope GELG, McArdle BM, Douglas JT, et al. Abnormal blood viscosity and hemostasis in long-standing retinal vein occlusion. Br J Ophthalmol. 1983;67(3):137–42.

    Article  CAS  Google Scholar 

  • Von Michel J. Die spontane Thrombose der Vena Centralis des Opticus. Graefes Arch Ophthalmol. 1878;24:37–70.

    Article  Google Scholar 

  • Weinberg D, Dodwell DG, Fern SA. Anatomy of arteriovenous crossings in branch retinal vein occlusion. Am J Ophthalmol. 1990;109(3):298–302.

    Article  CAS  Google Scholar 

  • Zhao JSS, Sperduto RD, Chew EY, Remalay NA. Arteriovenous crossing patterns in branch retinal vein occlusion. Ophthalmology. 1993;100(3):423–8.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Leong, B.C.S., Freund, K.B. (2020). Branch Retinal Vein Occlusion. In: Sheyman, A., Fawzi, A.A. (eds) Retinal Vascular Disease. Retina Atlas. Springer, Singapore. https://doi.org/10.1007/978-981-15-4075-2_5

Download citation

  • DOI: https://doi.org/10.1007/978-981-15-4075-2_5

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-15-4074-5

  • Online ISBN: 978-981-15-4075-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics